Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
德納維製藥股價上漲，因公司公佈了好於預期的第三季度每股收益結果，並啓動了20000萬美元的股票回購計劃。HC溫萊特重申對該股的買入評級。
Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
德納維製藥股價上漲，該公司公佈了優於預期的第三季度每股收益結果，並啓動了20000萬美元的股票回購計劃。瑞士信貸重申該股的買入評級。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間